Intracranial Hemorrhage and Polycystic Kidney Disease - Exploring the Link

What Is Polycystic Kidney Disease?

A genetic condition known as polycystic kidney disease (PKD) results in the growth of numerous fluid-filled cysts in the kidneys. In contrast to simple kidney cysts, which are typically benign and can develop later in life, PKD cysts can cause the kidneys to enlarge significantly. PKD is a type of chronic kidney disease (CKD) that impairs kidney function and can result in kidney failure. Other issues, such as high blood pressure, liver cysts, and issues with the blood vessels in the brain and heart, can also result from PKD.

What Is Intracranial Hemorrhage?

Intracranial hemorrhage is a form of stroke characterized by bleeding in the head. Due to its inability to store oxygen, the brain gets its nourishment and oxygen from a network of blood vessels. During a brain bleed, a blood vessel bursts or leaks blood. Blood accumulates or pools inside the skull and brain. Pressure builds up against the brain as a result, depriving its tissues and cells of oxygen and nourishment.

Bleeds from the brain are frequently caused by falls or severe injuries. They also frequently occur in those with uncontrolled hypertension. A potentially fatal medical emergency is a cerebral hemorrhage. Brain cells can die from oxygen deprivation in as little as three to four minutes. The best outcome comes from managing a brain bleed as soon as possible.

What Causes Polycystic Kidney Disease?

Polycystic kidney disease is caused by abnormal genes, meaning that the condition typically runs in families. Occasionally, a genetic mutation happens spontaneously, meaning neither parent carries a copy of the altered gene. There are two primary forms of polycystic kidney disease, each resulting from a unique genetic defect:

• ADPKD stands for autosomal dominant polycystic kidney disease. Its signs and symptoms typically appear in those between the ages of 30 and 40. This kind was formerly known as adult polycystic kidney disease, although it can also strike children. Only one parent must be afflicted for the disease to infect the children. Every child has a 50 percent chance of developing ADPKD if one parent has the condition. The majority of polycystic kidney disease cases are of this type.

• ARPKD stands for autosomal recessive polycystic kidney disease. Compared to ADPKD, this type is far less common. Frequently, the symptoms start to show up soon after birth. Occasionally, symptoms take longer to manifest in childhood or adolescence. Both parents must have aberrant genes for this disease to be passed on. Every baby has a 25 percent chance of developing this disorder if both parents have the gene.

Is Hypertension Linked to Intracranial Hemorrhage in Polycystic Kidney Disease?

In patients with PKD, hypertension may be a significant factor in the pathophysiology of cerebral hemorrhage and SAH. Long-term untreated hypertension may be the cause of intracerebral microaneurysms of the perforating arteries, which can rupture the artery or aneurysm and cause hemorrhaging in the surrounding tissue.

How Does Polycystic Kidney Disease Cause Intracranial Hemorrhage?

A cerebral or brain aneurysm, which is a bulging blood vessel caused by the weakening of the blood vessel wall, is the most serious potential consequence of PKD. Subarachnoid hemorrhage (SAH), or bleeding into the brain, can occur when aneurysms burst. This can result in irreversible brain damage or even death if treatment is not received before the aneurysm ruptures. Individuals with bigger aneurysms (>10 millimeters) are more likely to experience aneurysm rupture. A severe headache that starts suddenly, usually with a pop, and is often accompanied by nausea and vomiting is the most prevalent symptom of subarachnoid hemorrhage.

Aneurysms in the brain are estimated to affect three to seven percent of adults with ADPKD; if another member of the patient's family has experienced an intracranial aneurysm, this frequency rises to 12 to 15 percent. In patients with ADPKD, the risk of aneurysm development is roughly five times higher than in the general population. The greatest risk factor for developing an aneurysm is having a first-degree relative with a history of subarachnoid hemorrhage or intracranial aneurysm. Patients with ADPKD may also be more susceptible to aneurysm development if they smoke or have high blood pressure.

For those who are at high risk, early detection of intracranial aneurysms is advised that is, before symptoms appear. To screen for aneurysms before they burst, magnetic resonance angiography (MRA) or, if MRA is not available, a computed tomography (CT) scan is typically used.

Only high-risk patients, such as those who have experienced a prior rupture, have a positive family history of brain hemorrhage or stroke, exhibit warning signs (such as unusual headaches), or work in a high-risk profession (such as aviation), where losing consciousness would put them or others in grave danger, are advised to undergo routine screening.

How Is Polycystic Kidney Disease Diagnosed?

When an individual experiences flank or abdominal pain, or if there is a family history of ADPKD, the diagnosis of autosomal dominant polycystic kidney disease (ADPKD) is typically straightforward. The first diagnostic test advised is an imaging study, like an ultrasound, which can show multiple cysts on both kidneys. Although they may initially be normal in size, kidneys are typically enlarged. Moreover, cysts can be observed in the spleen, liver, and pancreas.

It could be more challenging to diagnose ADPKD in individuals without a family history. First, PKD diagnosis may be inferred from imaging test results (ultrasound, for example) for other purposes. A negative family history could result from a new mutation that has occurred, which affects 15 percent of ADPKD patients, or from family members who died of other causes before ADPKD was diagnosed and developed symptoms later. If there is no family history, the number of kidney cysts based on the patient's age (as previously mentioned) and additional clinical findings (liver cysts, for example) can be used to diagnose ADPKD. Rarely is genetic testing required in situations where the imaging diagnosis is unclear. Genetic testing is now much more accessible and reasonably priced.

What Is the PKD Treatment Plan?

Managing symptoms and preventing complications are the main objectives of PKD treatment. Preventing hypertension is the most crucial aspect of the therapy. Among the possible treatments are:

• Painkillers, except Ibuprofen, which is not advised since it could exacerbate kidney disease.

• Blood pressure prescription drugs.

• Antibiotics to treat urinary tract infections.

• A low-sodium diet.

• Diuretics help the body rid itself of extra fluid.

• Surgery to drain cysts and ease discomfort

Conclusion:

PKD patients may experience significant mortality and morbidity as a result of intracranial hemorrhage, whether it be cerebral hemorrhage or aneurysmal SAH. There have been reports of angiographic identification and surgical repair of unruptured berry aneurysms to stop SAH in these patients. Routine cerebral angiography and preventive surgery for asymptomatic aneurysms, however, remain unfeasible due to cost-effectiveness. In addition to being a significant risk factor for cerebral hemorrhage, hypertension is a common PKD complication that may also increase the likelihood of cerebral aneurysm rupture. Better management of hypertension may reduce the risk of SAH and cerebral hemorrhage.